中国甲状腺未分化癌患者中新发现的复发性改变基因
最常见改变基因为TP53(48%)、BRAF(24%)、PIK3CA(24%)和TERT启动子(21%),并发现RBM15(17%)、NOTCH2NL(14%)、CTNNA3(10%)和KATNAL2(10%)等新显著突变基因。NOTCH2NL拷贝数增益频率达41%且与表达升高相关,提示其可能为ATC新型候选驱动基因。
要点
- 中国ATC患者中TP53、BRAF、PIK3CA和TERT启动子改变频率较高,具有种族特异性。
- 新发现RBM15、NOTCH2NL、CTNNA3和KATNAL2等显著突变基因。
- NOTCH2NL拷贝数增益频率达41%并诱导表达升高,可能为候选驱动基因。
核心结论
- 中国ATC患者具有共享及种族特异性基因组特征,NOTCH2NL可能为ATC肿瘤发生的新型候选驱动基因。
主要发现
- 整个队列中位总生存期为3.0个月,受年龄、肿瘤大小及不同治疗策略等多临床特征影响。
- WES队列共检测到797个非沉默突变,最常见改变基因为TP53(48%)、BRAF(24%)、PIK3CA(24%)和TERT启动子(21%)。
- 新发现显著突变基因包括RBM15(17%)、NOTCH2NL(14%)、CTNNA3(10%)和KATNAL2(10%)。
- 基于WES的拷贝数变异分析显示NOTCH2NL增益高频(41%),并诱导其表达增加。
- 基因突变和拷贝数变异富集于磷脂酰肌醇3-激酶/AKT/哺乳动物雷帕霉素靶蛋白(mTOR)、NOTCH和WNT通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anaplastic thyroid cancer (ATC) is a rare but lethal malignancy, and few systematic investigations on genomic profiles of ATC have been performed in Chinese patients. METHODS: Fifty-four ATC patients in West China Hospital between 2010 to 2020 were retrospectively analyzed, while 29 patients with available samples were sequenced by whole-exome sequencing (WES). The associations between genomic alterations and clinical characteristics were statistically evaluated. RESULTS: The median overall survival was 3.0 months in the entire cohort, which was impacted by multiple clinical features, including age, tumor size, and different treatment strategies. In the WES cohort, totally 797 nonsilent mutations were detected; the most frequently altered genes were TP53 (48%), BRAF (24%), PIK3CA (24%), and TERT promoter (21%). Although these mutations have been well-reported in previous studies, ethnic specificity was exhibited in terms of mutation frequency. Moreover, several novel significantly mutated genes were identified including RBM15 (17%), NOTCH2NL (14%), CTNNA3 (10%), and KATNAL2 (10%). WES-based copy number alteration analysis also revealed a high frequent gain of NOTCH2NL (41%), which induced its increased expression. Gene mutations and copy number alterations were enriched in phosphatidylinositol 3-kinase/AKT/mechanistic target of rapamycin (mTOR), NOTCH, and WNT pathways. CONCLUSIONS: This study reveals shared and ethnicity-specific genomic profiles of ATC in Chinese patients and suggests NOTCH2NL may act as a novel candidate driver gene for ATC tumorigenesis.
引用
- Zhang L, Ren Z, Su Z, et al. Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer. J Clin Endocrinol Metab. 2021. PMID: 33428730. doi:10.1210/clinem/dgab014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。